Go beyond in single cell manipulation
Gentle and accurate single-cell injection and cytoplasmic biopsies.
Explore the remarkable capability to manipulate individual cells with the help of the FluidFM technology, including the FluidFM OMNIUM instrument and the CellEDIT service. This cutting-edge technology enables precise injections and extractions across a broad range of cell types and applications while ensuring that cell viability is maintained.
Explore the potential use of the FluidFM for temporal transcriptomics.
CRISPR Gene Editing
Find out more about the FluidFM workflow for precision CRISPR genome engineering.
Measure cell adhesion with the FluidFM technology in native environment.
Two ways to work with us
Instrument & ADD-ON for single-cell manipulation.
CRISPR Cell Line Editing Service
Monoclonal Cell Line
Hard-to-transfect mammalian cells
Discover all the resources available to provide you with key knowledge related to Life Science and Biology!
Explore 100+ publications in which FluidFM technology plays a major role. 8+ Ø impact factor.
Interesting insights on the company, applications, or persons working with FluidFM technology.
It is a great pleasure to see how much momentum the FluidFM has gained in the scientific community. It astounds me how many different FluidFM applications have been already demonstrated, and still think there is much more to explore both technologically (probes, electrical signals, combination with other instruments) and scientifically (biophysical questions), which is where we are focusing our efforts at ETH.
FluidFM is a highly versatile tool with huge potential in the field of single-cell studies. The instrument enables us to address several unanswered questions in the epigenetics field by pushing experimental boundaries.
FluidFM has provided us the chance to detach mammalian cells that were very strongly adhered to the substrate, in a systematic way and without any chemical modification of the cantilever; thus, allowing us to study cell behaviour in their natural state and environment.
FluidFM allows my team to efficiently capture adhesive forces of microbial pathogens and screen for new anti-adhesion molecules. I believe that FluidFM has the potential to shed much light onto anti-microbial strategies.
Cytosurge AG, founded in 2009, is a biotechnology company that manufactures and distributes cutting edge solutions based on its patented FluidFM ® technology.
By uniting the best features of microfluidics and force microscopy, Cytosurge provides innovative products and services to shift boundaries in single-cell gene engineering and omics. The Cytosurge vision into the future is to contribute to human wellbeing through advancements in single cell technologies.